Major restaurant chains warn about disruption and higher pricing from reciprocal tariffs
The National Restaurant Association warned about the impact of new reciprocal tariffs on the restaurant industry. CEO ...
Crinetics Pharma: Strong Progress With Multiple Indications And Upcoming PDUFA
Crinetics Pharma's Paltusotine shows strong Phase 3 results for acromegaly. Click here to find out why CRNX stock is a Buy.
Roche says MUSETTE trial did not meet primary endpoint
Group, announced that the Phase 3 MUSETTE trial comparing a high dose of Ocrevus intravenous infusion to the currently approved Ocrevus IV 600 mg dose in people with relapsing multiple sclerosis did ...